One line in the label, none in the trial tables
Saxenda® is liraglutide 3 mg, injected once a day for weight management in adults and in adolescents aged 12 to 17 who weigh more than 60 kg. [1] Its side effects are documented in three official places, and each counts them differently. The US tables include reactions seen in at least 2% of adults (3% of adolescents) and more often than on placebo; the EU table sorts reactions into frequency bands; the Canadian table goes down to 1%. [1][2][3]
Hair loss clears none of these thresholds. It turns up only in section 6.2 of the US label, a list of reactions reported after approval from a population of unknown size, where the label itself says frequency and causation cannot be reliably established. [1]
| Document | What it covers | Hair loss |
|---|---|---|
| US label, Table 2 [1] | Adults, 5 placebo-controlled trials, up to 56 weeks | Not listed |
| US label, Table 3 [1] | Adolescents 12–17, one 56-week trial | Not listed |
| US label, section 6.2 [1] | Voluntary post-approval reports for liraglutide | Alopecia listed, no rate |
| EU SmPC, section 4.8 [2] | Adults, 5 trials, plus post-marketing reports | Not listed |
| Canadian monograph, sections 8.2–8.5 [3] | Adults (≥1%), adolescents, less common and post-market reactions | Not listed |
What reporting databases and reviews add
A 2026 analysis of EudraVigilance, the European database of suspected side effects, looked for reactions reported with semaglutide, liraglutide and tirzepatide that the respective EU summaries do not list. Alopecia accounted for 0.81% of the liraglutide reports. [4] Reports like these come from patients and professionals who suspected a link; they cannot show that the medicine caused the hair loss, and they cannot tell you how often it happens.
A 2026 systematic review pooled 24 studies on GLP-1 medicines and hair loss. Semaglutide and tirzepatide had the highest reported rates and the most frequent safety signals, while liraglutide was studied less and generally showed lower reported risk. Telogen effluvium and pattern hair loss were the main types described, women appeared to be affected more often, and rapid weight loss stood out as a likely contributor. [5] The authors note that causation and timing still need prospective trials.
Why shedding can follow a weight-loss medicine
- Supported by the label: nothing beyond the listing itself. The Saxenda® label does not describe a mechanism for alopecia or tie it to a dose. [1]
- Proposed in research: the 2026 review points to fast weight loss as a trigger for telogen effluvium, a shift of many growing hairs into the resting phase at once. [5] Cleveland Clinic lists rapid weight loss and restrictive diets among the triggers. [7]
- General medical knowledge: MedlinePlus explains that physical or emotional stress can make a large share of scalp hair shed, and that crash diets low in protein are one recognised cause. [6] Eating much less, which is how liraglutide lowers weight according to the label, is a change the body notices. [1]
Timing on a daily injection
Telogen effluvium is delayed. Cleveland Clinic describes shedding that typically appears two to three months after the trigger, and MedlinePlus notes it may not be noticed for weeks to months, then eases over six to eight months. [6][7] Hair often comes out in handfuls while washing or brushing, as general thinning rather than bald patches. [6][7]
Set that against the Saxenda® schedule. The dose rises every week from 0.6 mg to 3 mg by week five, and the label asks prescribers to check weight at week 16 and stop treatment in adults who have not lost at least 4% of their starting weight. For adolescents, the check is a 1% fall in BMI after 12 weeks on the maintenance dose. [1] Shedding that began after the early weight change may therefore show up close to that review, which is a natural moment to mention it.
Other reasons hair thins
MedlinePlus lists many causes unrelated to any weight-loss medicine: inherited pattern hair loss, thyroid disease, anaemia, hormone changes, childbirth, high fever or major illness, surgery, alopecia areata (round bald patches), scalp infections, tight hairstyles and some medicines, including certain antidepressants, beta-blockers and birth control pills. [6] Several of these, such as thyroid problems and low iron, can be checked with blood tests when a clinician thinks they are likely. [6][7]
The pattern matters. Diffuse thinning a few months after a big change fits telogen effluvium; patches, scarring, scalp pain or redness point elsewhere. [6]
What official and clinical sources describe
For shedding linked to illness or medicine use, MedlinePlus says hair usually regrows without treatment, and Cleveland Clinic reports that most acute telogen effluvium resolves, with regrowth visible after the shedding period. [6][7] Cleveland Clinic advises against extreme or restrictive diets and suggests asking a healthcare provider before starting any supplement. [7]
The Saxenda® Medication Guide asks you to tell your provider about all medicines, vitamins and herbal supplements you take, and to talk to them about any side effect that bothers you or does not go away. [1] It does not suggest stopping the medicine because of hair changes; that is a decision for your prescriber.
Saxenda® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Trouble breathing, a swollen face or throat, or a widespread itchy rash | Emergency services (911 / 112) | Emergency | Medication Guide [1] |
| Hair loss in patches, or with scalp pain, itching, redness or scaling | Your doctor or a dermatologist | At your next appointment | MedlinePlus [6] |
| Thinning together with tiredness, feeling cold, muscle weakness or weight gain | Your doctor, to look for thyroid or other causes | At your next appointment | MedlinePlus [6] |
| A teenager on Saxenda® losing hair quickly | The teen’s prescriber | At your next appointment | MedlinePlus [6]; label [1] |
| Shedding that continues beyond six months | Your prescriber or a dermatologist | At your next appointment | Cleveland Clinic [7] |
